​REDWOOD CITY, California — Revolution Medicines announced positive results from a late-stage clinical trial evaluating its experimental drug daraxonrasib, showing a significant survival benefit for patients with advanced pancreatic cancer who had previously undergone treatment. According to the company, patients receiving the once-daily oral therapy lived a median of 13.2 months, compar

The ISDE India Edition 2026, a two-day international conference on esophageal cancer, was inaugurated on April 10, 2026, by Shri Nandamuri Balakrishna, Chairman & Managing Trustee of NBTRMCF, at The Westin Hyderabad, Madhapur. This is the first time the conference is being held in India, emphasizing the country’s growing role in esophageal cancer research and clinical expertise. The conference, in association with the Basavatarakam Indo-American Cancer Hospital & Research Institute

The NTR Trust is organizing a Thalassemia Run on May 10, 2026, to raise awareness about thalassemia, a genetic blood disorder that affects children. The event will feature 3K, 5K, and 10K runs at Jalavihar, Hyderabad, beginning at 5 AM. NTR Trust Managing Trustee Mrs. Nara Bhuvaneshwari, along with Thalassemia Run brand ambassador and Indian cricket star Mithali Raj, attended a press meet to encourage public participation and support. The run aims to highlight the importance of blood donation